SANFORDGUIDE

Antimicrobial Therapy, Inc.

about us

 
 

The Sanford Guides: Delivering Comprehensive Infectious Diseases Treatment Recommendations Where Needed Most—At The Point Of Care


  1. •Today, the world is at a crossroads on many levels, including medicine. The advent of modern antibiotics and the eradication of age-old diseases were triumphs of medicine and human determination in the latter half of the 20th century. But now, those accomplishments have been overshadowed by the AIDS epidemic, widespread resistant malaria and tuberculosis, concern over community-acquired MRSA and new diseases like SARS and H1N1 flu. The challenge remains how best to deliver relevant information where it is most needed. For infectious diseases, this means having the right information at hand to make timely, effective treatment decisions at the point of care—whether an urban ICU, a crowded HIV ward in Kampala, a medical relief tent in Sichuan, or an overworked primary care clinic.


  1. •The Sanford Guides have provided up-to-date guidelines and recommendations for treatment of infectious diseases for 40 years. Comprehensive content with extensive source references, user-friendly tabular format, and portability are hallmarks that make the Sanford Guide the “gold standard” reference in its field.


  1. •Drawn entirely from published medical literature, The Sanford Guide to Antimicrobial Therapy consistently delivers convenient, comprehensive recommendations for treatment and prevention of bacterial, fungal, viral, parasitic and mycobacterial infections, surgical prophylaxis, and ancillary information covering pharmacology, adverse effects, drug-drug interactions and dose adjustments, all supported by commentary and references. The Sanford Guide to HIV/AIDS Therapy provides the same broad coverage for HIV disease and AIDS, with an added focus on treatment options in areas of the world where neither expensive diagnostic technology nor drugs may be available.


  1. •The Sanford Guides are updated annually, reflecting new drugs, shifting resistance patterns, the emergence of new diseases, and the changing availability and efficacy of anti-infective therapies. The format of both these books is uniquely designed for use in the field--whether hospital wards, physician examining rooms, walk-in clinics or wherever treatment decisions are made. Whether in electronic or print format, the content is current, concise and easy to use.


  1. •The Sanford Guides do not replace textbooks, journals, or official and professional guidelines; instead, the Sanford Guides allow the busy clinician, pharmacist, nurse or other professional to carry the essentials of that information in their pocket. Treatment decisions are not made in the library, but at the point of care. In today’s complex world of infectious diseases, having the essential treatment guidelines in your pocket makes for consistent, informed decisions where it counts the most--patient care.

 

Antimicrobial Therapy, Inc.
P.O. Box 276
11771 Lee Hwy
Sperryville, VA 22713
USA

T: 540-987-9480
F: 540-987-9486
E: info@sanfordguide.com

Editorial Board

  1. •David N. Gilbert, M.D. is Director of the Earl A. Chiles Research at Providence Portland Medical Center in Portland Oregon. He is also Professor of Medicine at Oregon Health Sciences University. Dr. Gilbert’s involvement with the Sanford Guide began during his infectious diseases fellowship under Jay P. Sanford, M.D., at Southwestern Medical School in Dallas in the 1960s. He served as President of the Infectious Diseases Society of America (IDSA) in 2002.

  2. •Robert C. Moellering, Jr., M.D. is the Shields-Warren Malinckrodt Professor of Medical Research at Harvard Medical School in Boston, Massachusetts. Dr. Moellering is a leading expert on antimicrobial mechanisms of action and resistance. He served as President of IDSA in 1991. He received the prestigious Maxwell Finland Award in 2006 from the National Foundation for Infectious Diseases and the IDSA’s lifetime achievement award in 2008.

  3. •George M. Eliopoulos, M.D. is Professor of Medicine at Harvard Medical School and Chief of the James L. Tullis Firm at Beth Israel Deaconess Hospital in Boston, Massachusetts. An expert on antimicrobial resistance, he also serves as Editor-in-Chief of Antimicrobial Agents and Chemotherapy.

  4. •Michael S. Saag, M.D. is Professor of Medicine and Director of the Center for AIDS Research at the University of Alabama at Birmingham. Dr. Saag is an internationally recognized AIDS expert and serves as HIV Medicine Association member of the IDSA Board of Directors.

  5. •Henry F. “Chip” Chambers, M.D. is Professor of Medicine at the University of California at San Francisco and Chief of Infectious Diseases at San Francisco General Hospital. His academic interests include antimicrobial resistance; genetics, molecular basis, and epidemiology of methicillin-resistant Staphylococcus aureus; staphylococcal infections and tuberculosis.

  6. Contributing Editor

  7. •Andrew T. Pavia, M.D. is Professor of Pediatrics & Medicine and Chief of Pediatric Infectious Diseases at University of Utah School of Medicine in Salt Lake City. Dr. Pavia’s interests have focused on HIV/AIDS and the epidemiology of emerging infections and vaccine-preventable diseases. He serves as Chairman of the Pandemic Influenza Task Force of the IDSA.

    Emeritus

  8. •Jay P. Sanford, M.D. (1928-1996)

  9. •Merle A. Sande, M.D. (1935-2007)

Management

  1. •Jeb C. Sanford, President and Chief Executive Officer, is a graduate of Southern Methodist University and St. Mary’s University School of Law. He began his career as a legislative staffer for a member of Congress and then on the Minority Counsel staff of the House Interstate and Foreign Commerce Committee. After serving as a law clerk for the Texas Supreme Court, he practiced law in Washington, D.C. and San Antonio, Texas before joining the Environment Division of the U.S. Department of Justice in Washington where he spent nine years as a Trial Lawyer, Senior Lawyer and Assistant Chief of Environmental Enforcement. He has been a director of the corporation since 1979 and assumed full-time responsibility for management of the company in 1995.

  2. •Dianne H. Sanford, General Counsel, is a graduate of Cornell University and Harvard Law School.  She began her legal career as an Assistant United States Attorney in the District of Columbia as a felony prosecutor and then served in the Environment Division of the U.S. Department of Justice in the Wildlife and Marine Resources and Environmental Enforcement Sections, as a Trial Lawyer, Senior Lawyer and Assistant Section Chief. After leaving Justice, she was a partner in the Environmental practice at Akin, Gump, Strauss, Hauer & Feld in Washington, D.C. She later served as an Assistant Attorney General for the State of Vermont.  She has served as  a member of the Company’s Board of Directors since 1996, as its Secretary/Treasurer since 1998 and General Counsel since 2001.

  3. Staff   

  4. •Sherry M. Golden is Customer Service Manager.  She joined the company in 2005 from a background of customer and logistical support services.


  1. •Thomas Golden serves as an information technology specialist and customer service representative. He joined the company in 2008.


  1. •Virginia L. Sanford is a customer service representative. She is a 2008 graduate of the University of Colorado (Boulder) and joined the company in 2010.


  1. •Lin Chunmei received her undergraduate degree at Beijing Normal University and her M.A. in economics at Princeton University. She serves as the company’s representative in Beijing, China.